Low-Dose Azacitidine (AZA) for Treatment of Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapse after Allogeneic Hematopoietic Cell Transplant (HCT)

• Published in: Biology of blood and marrow transplantation 2016-03, Vol.22 (3), p.S212-S213
• Main Authors: Ueda, Masumi, MD, Lazarus, Hillard M., MD, Cooper, Brenda, MD, Caimi, Paolo, MD, Creger, Richard, PharmD, Little, Jane A., MD, Baer, Linda, CNP, Brister, Lauren, CNP, AOCNP, Malek, Ehsan, MD, Metheny, Leland, MD, Tomlinson, Benjamin, MD, Gerson, Stan L., MD, Oran, Betul, MD, de Lima, Marcos, MD
• Format: Article
• Language: English
• Subjects: Hematology, Oncology and Palliative Medicine
• ISSN: 1083-8791; 1523-6536
• DOI: 10.1016/j.bbmt.2015.11.610